In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds

Epilepsy is a neurological disorder affecting more than 50 million people worldwide. It can be controlled by antiepileptic drugs (AEDs) but more than 30% patients are still resistant to AEDs. To overcome this problem, researchers are trying to develop novel approaches to treat epilepsy including the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Shilu, Faheem, Muhammad, Al-Malki, Abdulrahman L, Kumosani, Taha A, Qadri, Ishtiaq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2015
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479051/
https://www.ncbi.nlm.nih.gov/pubmed/26124559
http://dx.doi.org/10.6026/97320630011189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479051/
https://www.ncbi.nlm.nih.gov/pubmed/26124559
http://dx.doi.org/10.6026/97320630011189

Ejemplares similares